Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Shotaro TSURUTA"'
Autor:
Naota Taura, Tatsuki Ichikawa, Hisamitsu Miyaaki, Yoshiko Kadokawa, Takuya Tsutsumi, Shotaro Tsuruta, Yuji Kato, Osami Inoue, Noboru Kinoshita, Kazuo Ohba, Hiroyuki Kato, Kazuyuki Ohata, Junichi Masuda, Keisuke Hamasaki, Hiroshi Yatsuhashi, Kazuhiko Nakao
Publikováno v:
Gastroenterology Research and Practice, Vol 2012 (2012)
Background. HCV infection is associated with lipid disorders because this virus utilizes the host lipid metabolism to sustain its life cycle. Several studies have indicated that higher concentrations of serum cholesterol and LDL before treatment are
Externí odkaz:
https://doaj.org/article/b3efbb25cd7b4a9583fb043a98042817
Autor:
Kouji Joko, Yasushi Uchida, Masayuki Kurosaki, Hironori Ochi, Hiroshi Watanabe, Tohru Goto, Kaoru Tsuchiya, Takuji Akamatsu, Chitomi Hasebe, Toshie Mashiba, Akari Mitsuda, Shotaro Tsuruta, Yoshiko Nakamura, Namiki Izumi, Takero Koike, Hiroyuki Kimura
Publikováno v:
Hepatology Research. 46:251-258
Aim To investigate, in a large number of cases at multiple institutions, the effects and limitations of antiviral therapy for hepatitis C following treatment of hepatocellular carcinoma (HCC) in clinical practice. Methods Retrospective analysis was p
Autor:
Takuya Tsutsumi, Tatsuki Ichikawa, Jun-ichi Masuda, Shotaro Tsuruta, Kazuhiko Nakao, Keisuke Hamasaki, Noboru Kinoshita, Yuji Kato, Kazuo Ohba, Hiroshi Yatsuhashi, Kazuyuki Ohata, Hisamitsu Miyaaki, Osami Inoue, Hiroyuki Kato, Naota Taura, Yoshiko Kadokawa
Publikováno v:
Gastroenterology Research and Practice
Gastroenterology Research and Practice, Vol 2012 (2012)
Gastroenterology Research and Practice, Vol 2012 (2012)
Background. HCV infection is associated with lipid disorders because this virus utilizes the host lipid metabolism to sustain its life cycle. Several studies have indicated that higher concentrations of serum cholesterol and LDL before treatment are
Autor:
Tomoyuki ARITOMI, Hiroki ISHIKAWA, Shin-ichiro HIGASHI, Daisaku HIDA, Keisuke HAMASAKI, Shotaro TSURUTA, Kazuhiko NAKAO, Yuji KATO, Keisuke NAKATA, Katsumi EGUCHI, Kan TORIYAMA
Publikováno v:
Kanzo. 44:27-31
Autor:
Kouji, Joko, Tohru, Goto, Hiroshi, Watanabe, Akari, Mitsuda, Yasushi, Uchida, Chitomi, Hasebe, Shotaro, Tsuruta, Hiroyuki, Kimura, Takero, Koike, Takuji, Akamatsu, Toshie, Mashiba, Hironori, Ochi, Yoshiko, Nakamura, Kaoru, Tsuchiya, Masayuki, Kurosaki, Namiki, Izumi
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 46(4)
To investigate, in a large number of cases at multiple institutions, the effects and limitations of antiviral therapy for hepatitis C following treatment of hepatocellular carcinoma (HCC) in clinical practice.Retrospective analysis was performed of 1
Autor:
Katsumi Eguchi, Yuji Kato, Akio Ido, Nobuko Ishii, Hiroki Ishikawa, Kazuhiko Nakao, Toshihito Ueki, Shotaro Tsuruta, Keisuke Nakata, F Mawatari
Publikováno v:
Biochemical and Biophysical Research Communications. 287:1034-1040
In the present study, to achieve more selective and efficient therapeutic gene expression in hepatoma cells, we compared the therapeutic efficacies of the retroviral vectors expressing the herpes simplex virus thymidine kinase (HSV-tk) gene by the α
Autor:
Katsumi Eguchi, Hiroyuki Mazume, Daisaku Hida, Keisuke Hamasaki, Yuji Kato, Kazuhiko Nakao, Shotaro Tsuruta, Keisuke Nakata
Publikováno v:
Journal of Hepatology. 30:904-910
Background/Aims: The ras proto-oncogene encodes a small GTP-binding protein (Ras) which regulates cell growth and differentiation by relaying signals from the cell surface to the nucleus. In the present study, the role of Ras signal transduction path
Autor:
Manabu Daikoku, Nobuko Ishii, Kaoru Inokuchi, Shotaro Tsuruta, Keisuke Nakata, Kazuhiko Nakao, Yuji Kato, Tasuku Nomura, Shigenobu Nagataki, Akio Ido
Publikováno v:
International Hepatology Communications. 4:351-357
The transcription activator, Interferon regulatory factor-1 (IRF-1), has been shown to function as a tumor suppressor and the structurally related interferon regulatory factor-2 (IRF-2) as a counterpart. The loss of IRF-1 function or overexpression o
Autor:
Tatsuki Ichikawa, Hidetaka Shibata, Sachiko Fukuda, Yasuhiro Kamo, Shotaro Tsuruta, Takuya Honda, Takehiro Matsumoto, Hajime Isomoto, Kazuhiko Nakao, Emi Yoshimura, Tohei Yamaguchi, Hisamitsu Miyaaki, Naota Taura, Yoko Kubota, Fuminao Takeshima, Shinjiro Uchida, Takuya Tsutsumi
Publikováno v:
Experimental and Therapeutic Medicine
α-fetoprotein (AFP) is a tumor marker of hepatocellular carcinoma (HCC) and has also been reported to reflect the effectiveness of long-term low-dose interferon (IFN) therapy in hepatitis C virus (HCV)-infected patients with chronic liver disease. T
Autor:
Kan Toriyama, H Kamito, Y Shibata, Kazuhiko Nakao, Muro T, Shotaro Tsuruta, Yuji Kato, Keisuke Nakata, Tetsuhiko Arima, Shigenobu Nagataki
Publikováno v:
Oncology reports. 3(1)
To elucidate the difference in the liver carcinogenetic process during hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, non-tumorous liver tissues obtained from 10 patients who developed HBV-associated hepatocellular carcinoma (HCC) wi